Table 2. Univariate and multivariate analyses of clinicopathologic characteristics for DFS in luminal breast cancer.

Variable	Univariate analysis		Multivariate analysis
	HR(95% CI)	P-value	HR(95% CI)	P-value
LMR(<5.2; ≥5.2)	0.560(0.395-0.793)	0.001	0.582(0.408-0.831)	0.003
Lymph node status	1.748(1.167-2.620)	0.007	1.560(0.986-2.468)	0.057
Chemotherapy	1.676(1.143-2.458)	0.008	1.527(1.014-2.301)	0.043
Menopause status	0.827(0.594-1.153)	0.262	0.815(0.500-1.327)	0.410
Age	1.158(0.830-1.614)	0.389	1.118(0.683-1.830)	0.658
Tumor size	0.982(0.653-1.478)	0.931	0.852(0.556-1.305)	0.460
Histological grade status	0.996(0.635-1.560)	0.985	0.889(0.540-1.464)	0.645
Ki 67 status	1.055(0.757-1.469)	0.753	1.108(0.789-1.556)	0.552

Bold values are significant (P<0.05). DFS, disease-free survival; LMR, lymphocyte-to-monocyte ratio; HR, hazard ratio